Previous studies have demonstrated that endothelin is present in the ovine endometrium and increases at around the expected time of implantation. To 
Introduction
Endothelins (ETs) are a family of three 21 amino acid peptides originally described for their potent vasoconstric¬ tor actions (Masaki 1993) . They are present in the uteri of sheep , women (Cameron et al. 1992 , Ecónomos et al. 1992 ) and rabbit (Orlando et al. 1990 , Maggi et al. 1991 . In sheep, the tissue content of ET-1, the principal isoform present, increases towards the end of the oestrous cycle and at the time of implantation, and is localised principally in epi¬ thelial cells at these times ). In the endometrium of women ET-1 mRNA and peptide are localised in, and ET-1 is released by, the same cells (Ecónomos et al. 1992 , Marsh et al. 1994 ). The effects of endothelins are modulated through two subtypes of receptor, ETA and ETB, which are members of the G-protein linked receptor superfamily (Masaki et al. 1994 ). The mRNA for both these receptor subtypes and specific binding sites are present in the uterus of women throughout the menstrual cycle (O'Reilly et al. 1992 ). In the sheep uterus the presence and localisation of endothelin receptors has not been examined. Although the functions of ETs in the uterus have yet to be clearly defined, it has been proposed that ET plays an important regulatory role in the vasculature by constriction of spiral arterioles for the initiation of menstruation ).
regulatory functions including mitogenic actions -where their effects are comparable to those of cytokines (Battistini et al. 1993) . In sheep and other ruminants, there is a relatively long period of preimplantation development, characterised by rapid blastocyst expansion during the 4 days prior to implantation (Bindon 1971) . During the implantation period there is considerable angiogenesis (Reynolds & Redmer 1992) and endometrial and tro¬ phoblast mitogenesis. Therefore, the sheep is a good model in which to examine preimplantation mitogenic stimuli.
This study has characterised the ET content in the uterine lumen during the oestrous cycle and early preg¬ nancy around the time of implantation in the ewe. The cellular source of endometrial ET was determined using cultures of purified cells and the localisation of ETs in the conceptus was demonstrated using immunohistochemical techniques. The presence of specific binding sites to ET was determined in the uterus and conceptus, and localised during the peri-implantation period.
Materials and Methods

Animals
Parous Comiédale ewes («=80) were mated with either vasectomised or intact rams as described previously (Salamonsen et al. 1986 ). On the evening prior to surgery, animals were penned and food and water withheld. Ewes on days 4 (n=5 per group unless specified otherwise), 10, 12, 14 (n-T) and 16 (3) after oestrus (day 0), and on days 4, 7 (4), 8 (4), 9 (4), 10, 12, 14 (9) , 15 (6), 16 (7) of pregnancy were anaesthetised, the uterus exposed through a midline incision and the cervix clamped as described previously (Salamonsen et al. 1986 ). Uteri were flushed with 20 ml saline and pregnancy was confirmed by the presence of a conceptus. Ligand binding and autoradiography Binding sites were measured, characterised and localised by autoradiography using the method described by Molenaar et al. (1993) . Serial sections (10 µ ) of full thickness myometrium and endometrium were cut and thaw-mounted onto gelatin-coated slides. Preliminary ex¬ periments established that specific binding was time-and temperature-dependent and the optimal conditions were 2 h and 23°C as described previously. Binding assays were performed using "T-labelled ET-1 prepared as previously described Fig. 3d ) with a dissociation constant (Kd) of 0-7 ±0-3 nM (n=A). Both ET receptor subtypes were present as shown by the biphasic displacement curve of T-labelled ET-1 by the specific ETB receptor agonist BQ3020 (Fig. 5b) . Specific ET binding sites were localised in endometrium obtained on day 16 of pregnancy by autoradiography (Fig. 6a) (Fig. 6b) . ET receptors were also present in concep¬ tus tissues (predominantly trophoblast) (Fig. 7) . In all conceptus tissues examined, specific "T-labelled ET binding was saturable and displaceable by unlabelled ET-1
(1 µ ; Fig. 7) , with a Kd of 0-6 ±0-4 nM (u=5). -10-11 -io-io 10-9 -e 10-7 -e 10"5 Log BQ3020 (M) figure 5 . Displacement of specific 12sI-labelled ET-1 binding by (a) . This is somewhat different from that in women (Cameron et al. 1993) where endometrial extracts contained all three ET isoforms and their mRNAs, and although ET-1 was the most prevalent isoform, there was no correlation with either the abundance of isoform or stage of cycle.
From in vitro studies on purified cell populations, it has been shown that glandular epithelial cells are the principal site of ET production by the endometrium. There was little or no release of ET immunoreactivity by stromal cells and no detectable ET was released into medium con¬ ditioned by conceptus tissues, indicating that ET measured in the uterine lumen is likely to be derived from epithelial cells of the endometrium. This is in agreement with studies in women demonstrating that cultured endometrial epithelial cells release between 5 and 20 times more ET-1 than stromal cells (Marsh et al. 1994) . It remains to be established whether release of ET by ovine endometrial epithelial cells is directional, although there is evidence for the basal release of ETs by endothelial cells (Wagner et al. 1992) .
The production of ET by cultured ovine endometrial epithelial cells was stimulated by FCS which contains both steroids and growth factors although the precise factor(s) (Bacon et al. 1995) and other tissues (Masaki et al. 1994) . ET receptors were localised principally on the endometrial luminal and glandular epithelium and the most intense immunostaining for ET was also localised at these sites (Riley et (Hirata et al. 1989 , Bobik et al. 1990 ), vascular pericytes (Yamagishi et al. 1993 ), mesenchymal cells including human placental stromal cells (Fant et al. 1992) , and epithelial cells of the thyroid (Eguchi et al. 1993 ), either on their own or as co-mitogens with other growth factors (Battistini et al. 1993 ). The high concentrations of ET-1 present in the uterine lumen may have a stimulatory role in the mitogenesis associated with en¬ dometrial and conceptus remodelling and angiogenesis that occurs during implantation and early placentation.
